Literature DB >> 16076297

The time course of the bilateral release of cytokines and mediators after unilateral nasal allergen challenge.

M Wagenmann1, L Schumacher, C Bachert.   

Abstract

BACKGROUND: Late phase reactions after allergen challenge can be understood as a correlate of the inflammatory reaction in allergic rhinitis.
METHODS: To investigate which cytokines are involved in it and to dissect direct and indirect effects of nasal allergen challenge, we performed unilateral nasal allergen provocation with the disc method in 12 seasonal allergic volunteers. Symptom scores, nasal secretions and nasal airflow were quantified. In the secretions that were collected in the early phase and for 8 h after provocation, we measured histamine, and the cytokines interleukin (IL)-1beta, IL-8, IL-4, and the natural antagonist of IL-1beta, IL-1 receptor type 1 (IL-1Ra) using enzyme-linked immunosorbent (ELISA)-assays. Control challenges with diluent instead of allergen were performed in all subjects.
RESULTS: We demonstrated a bilateral increase in nasal secretion weights in the early and late phase. Histamine was significantly increased in the early and late phase in nasal secretions from both nostrils. IL-1beta increased in the late phase only, where it was also found on the unchallenged, contralateral side. Its antagonist IL-1Ra was found in very high quantities (1000-fold higher than IL-1beta) but demonstrated only marginal changes after provocation. IL-8 was increased in both nostrils early and late after challenge, whereas IL-4 was significantly elevated in the late phase.
CONCLUSIONS: We described the time course of mediator and cytokine release into nasal secretions after allergen challenge. We hypothesize that the observed indirect effects on the unchallenged, contralateral side can be at least partially attributed to neuronal reflexes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16076297     DOI: 10.1111/j.1398-9995.2005.00867.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  13 in total

1.  [Nasal provocation with increased ASA dose: improved "non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated disease" (N‑ERD) detection rate in chronic rhinosinusitis patients].

Authors:  U Förster-Ruhrmann; W Behrbohm; G Pierchalla; A J Szczepek; J W Fluhr; H Olze
Journal:  HNO       Date:  2019-08       Impact factor: 1.284

Review 2.  Cytokine profiles in allergic rhinitis.

Authors:  Guy Scadding
Journal:  Curr Allergy Asthma Rep       Date:  2014-05       Impact factor: 4.806

3.  [Local allergic rhinitis to Alternaria alternata : Evidence for local IgE production exclusively in the nasal mucosa].

Authors:  L Klimek; C Bardenhewer; M Spielhaupter; C Harai; K Becker; O Pfaar
Journal:  HNO       Date:  2015-05       Impact factor: 1.284

4.  Establishment of a new animal model of allergic rhinitis with biphasic sneezing by intranasal sensitization with Staphylococcal enterotoxin B.

Authors:  Rong Sun; Xinye Tang; Hongbing Yao; Suling Hong; Yang Yang; Wei Kou; Ping Wei
Journal:  Exp Ther Med       Date:  2015-05-21       Impact factor: 2.447

Review 5.  [Local (exclusive) IgE production in the nasal mucosa. Evidence for local allergic rhinitis].

Authors:  L Klimek; L von Bernus; O Pfaar
Journal:  HNO       Date:  2013-03       Impact factor: 1.284

6.  In Vivo Anti-Inflammatory Effect of H1 Antihistamines in Allergic Rhinitis: A Randomized Clinical Trial.

Authors:  Corina I Bocşan; Adriana I Bujor; Nicolae Miron; Ştefan C Vesa; Diana Deleanu; Anca D Buzoianu
Journal:  Balkan Med J       Date:  2015-10-01       Impact factor: 2.021

7.  The Allergic Rhinitis - Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies.

Authors:  Anne K Ellis; Mena Soliman; Lisa Steacy; Marie-Ève Boulay; Louis-Philippe Boulet; Paul K Keith; Harissios Vliagoftis; Susan Waserman; Helen Neighbour
Journal:  Allergy Asthma Clin Immunol       Date:  2015-04-24       Impact factor: 3.406

8.  Precision medicine reaching out to the patients in allergology - a German-Japanese workshop report.

Authors:  Oliver Pfaar; Katharina Blumchen; Eistine Boateng; Eckard Hamelmann; Tomohisa Iinuma; Thilo Jakob; Susanne Krauss-Etschmann; Hiroyuki Nagase; Saeko Nakajima; Taiji Nakano; Harald Renz; Sakura Sato; Christian Taube; Martin Wagenmann; Thomas Werfel; Margitta Worm; Kenji Izuhara
Journal:  Allergol Select       Date:  2021-05-27

9.  The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms.

Authors:  Ralf Baumann; Matthaeus Rabaszowski; Igor Stenin; Maria Gaertner-Akerboom; Kathrin Scheckenbach; Jens Wiltfang; Joerg Schipper; Martin Wagenmann
Journal:  Clin Transl Allergy       Date:  2012-08-01       Impact factor: 5.871

10.  Evaluation of clinical and immunological responses: a 2-year follow-up study in children with allergic rhinitis due to house dust mite.

Authors:  Heleen Moed; Roy Gerth van Wijk; Rudi W Hendriks; J C van der Wouden
Journal:  Mediators Inflamm       Date:  2013-04-27       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.